Jun 12, 2018 8:00am EDT Artelo Biosciences Enters Into Global R&D Partnership With Syngene International And Aptus Clinical For The Clinical Development Of ART27.13 In Oncology
Apr 18, 2018 8:00am EDT Artelo Biosciences And Stony Brook University Announce Worldwide License Agreement For Portfolio Of Fatty Acid Binding Protein Inhibitor Drug Candidates
Jan 30, 2018 8:00am EST Artelo Biosciences And The NEOMED Institute Enter Into An Exclusive Global Option And License Agreement